COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER
The invention provides an anti-CCR9 antibody molecule for use in a method of treatment of cancer in a mammalian subject wherein the anti-CCR9 antibody molecule is administered simultaneously, sequentially or separately with a chemotherapeutic agent selected from the group consisting of: vincristine,...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DELGADO ÁLVAREZ, Marisa PÉREZ DÍAZ, Amparo SIMÓN BUELA, Laureano GARRIDO CUESTA, Pablo SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia KREMER BARÓN, Leonor Judith GARCÍA SANZ, José Alberto |
| description | The invention provides an anti-CCR9 antibody molecule for use in a method of treatment of cancer in a mammalian subject wherein the anti-CCR9 antibody molecule is administered simultaneously, sequentially or separately with a chemotherapeutic agent selected from the group consisting of: vincristine, docetaxel, paclitaxel, nanoparticle albumin-bound paclitaxel, and vinblastine, wherein said anti-CCR9 antibody molecule and said chemotherapeutic agent are not conjugated together. Also provided are related methods of treatment. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4472741A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4472741A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4472741A13</originalsourceid><addsrcrecordid>eNrjZPBx9vd18vRzDPH091MI8XANcgyIVACKBQR5Bnv6uSs4-oV46jo7B1mCWU7-LpFAhotCmKefM1BFiKefq4Kbf5CCs6Ofs2sQDwNrWmJOcSovlOZmUHBzDXH20E0tyI9PLS5ITE7NSy2Jdw0wMTE3MjcxdDQ0JkIJAG3ULZg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER</title><source>esp@cenet</source><creator>DELGADO ÁLVAREZ, Marisa ; PÉREZ DÍAZ, Amparo ; SIMÓN BUELA, Laureano ; GARRIDO CUESTA, Pablo ; SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia ; KREMER BARÓN, Leonor Judith ; GARCÍA SANZ, José Alberto</creator><creatorcontrib>DELGADO ÁLVAREZ, Marisa ; PÉREZ DÍAZ, Amparo ; SIMÓN BUELA, Laureano ; GARRIDO CUESTA, Pablo ; SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia ; KREMER BARÓN, Leonor Judith ; GARCÍA SANZ, José Alberto</creatorcontrib><description>The invention provides an anti-CCR9 antibody molecule for use in a method of treatment of cancer in a mammalian subject wherein the anti-CCR9 antibody molecule is administered simultaneously, sequentially or separately with a chemotherapeutic agent selected from the group consisting of: vincristine, docetaxel, paclitaxel, nanoparticle albumin-bound paclitaxel, and vinblastine, wherein said anti-CCR9 antibody molecule and said chemotherapeutic agent are not conjugated together. Also provided are related methods of treatment.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241211&DB=EPODOC&CC=EP&NR=4472741A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241211&DB=EPODOC&CC=EP&NR=4472741A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DELGADO ÁLVAREZ, Marisa</creatorcontrib><creatorcontrib>PÉREZ DÍAZ, Amparo</creatorcontrib><creatorcontrib>SIMÓN BUELA, Laureano</creatorcontrib><creatorcontrib>GARRIDO CUESTA, Pablo</creatorcontrib><creatorcontrib>SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia</creatorcontrib><creatorcontrib>KREMER BARÓN, Leonor Judith</creatorcontrib><creatorcontrib>GARCÍA SANZ, José Alberto</creatorcontrib><title>COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER</title><description>The invention provides an anti-CCR9 antibody molecule for use in a method of treatment of cancer in a mammalian subject wherein the anti-CCR9 antibody molecule is administered simultaneously, sequentially or separately with a chemotherapeutic agent selected from the group consisting of: vincristine, docetaxel, paclitaxel, nanoparticle albumin-bound paclitaxel, and vinblastine, wherein said anti-CCR9 antibody molecule and said chemotherapeutic agent are not conjugated together. Also provided are related methods of treatment.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBx9vd18vRzDPH091MI8XANcgyIVACKBQR5Bnv6uSs4-oV46jo7B1mCWU7-LpFAhotCmKefM1BFiKefq4Kbf5CCs6Ofs2sQDwNrWmJOcSovlOZmUHBzDXH20E0tyI9PLS5ITE7NSy2Jdw0wMTE3MjcxdDQ0JkIJAG3ULZg</recordid><startdate>20241211</startdate><enddate>20241211</enddate><creator>DELGADO ÁLVAREZ, Marisa</creator><creator>PÉREZ DÍAZ, Amparo</creator><creator>SIMÓN BUELA, Laureano</creator><creator>GARRIDO CUESTA, Pablo</creator><creator>SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia</creator><creator>KREMER BARÓN, Leonor Judith</creator><creator>GARCÍA SANZ, José Alberto</creator><scope>EVB</scope></search><sort><creationdate>20241211</creationdate><title>COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER</title><author>DELGADO ÁLVAREZ, Marisa ; PÉREZ DÍAZ, Amparo ; SIMÓN BUELA, Laureano ; GARRIDO CUESTA, Pablo ; SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia ; KREMER BARÓN, Leonor Judith ; GARCÍA SANZ, José Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4472741A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DELGADO ÁLVAREZ, Marisa</creatorcontrib><creatorcontrib>PÉREZ DÍAZ, Amparo</creatorcontrib><creatorcontrib>SIMÓN BUELA, Laureano</creatorcontrib><creatorcontrib>GARRIDO CUESTA, Pablo</creatorcontrib><creatorcontrib>SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia</creatorcontrib><creatorcontrib>KREMER BARÓN, Leonor Judith</creatorcontrib><creatorcontrib>GARCÍA SANZ, José Alberto</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DELGADO ÁLVAREZ, Marisa</au><au>PÉREZ DÍAZ, Amparo</au><au>SIMÓN BUELA, Laureano</au><au>GARRIDO CUESTA, Pablo</au><au>SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia</au><au>KREMER BARÓN, Leonor Judith</au><au>GARCÍA SANZ, José Alberto</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER</title><date>2024-12-11</date><risdate>2024</risdate><abstract>The invention provides an anti-CCR9 antibody molecule for use in a method of treatment of cancer in a mammalian subject wherein the anti-CCR9 antibody molecule is administered simultaneously, sequentially or separately with a chemotherapeutic agent selected from the group consisting of: vincristine, docetaxel, paclitaxel, nanoparticle albumin-bound paclitaxel, and vinblastine, wherein said anti-CCR9 antibody molecule and said chemotherapeutic agent are not conjugated together. Also provided are related methods of treatment.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4472741A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A49%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DELGADO%20%C3%81LVAREZ,%20Marisa&rft.date=2024-12-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4472741A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |